Tandem Diabetes Care, Inc. Interest Expense Nonoperating
Tandem Diabetes Care, Inc. (TNDM) reported Interest Expense Nonoperating of $2.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-06
- Tandem Diabetes Care, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $2.45M, a 28.61% increase year-over-year.
- Tandem Diabetes Care, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $2.20M, a 18.37% increase year-over-year.
- Tandem Diabetes Care, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $2.08M, a 11.56% increase year-over-year.
- Tandem Diabetes Care, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $2.06M, a 10.72% increase year-over-year.
- Tandem Diabetes Care, Inc. interest expense nonoperating for fiscal 2025 was $7.91M, a 6.64% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. interest expense nonoperating for fiscal 2024 was $7.42M, a 24.96% decline from fiscal 2023.
- Tandem Diabetes Care, Inc. interest expense nonoperating for fiscal 2023 was $9.88M, a 59.18% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. interest expense nonoperating for fiscal 2022 was $6.21M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.45M 10-Q · filed 2026-08-06 | $4.65M 10-Q · filed 2026-08-06 | $6.73M derived: sum of 3 quarters · filed 2026-08-06 | $8.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.20M 10-Q · filed 2026-05-07 | $4.28M derived: sum of 2 quarters · filed 2026-05-07 | $6.34M derived: sum of 3 quarters · filed 2026-05-07 | $8.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.14M derived: sum of 2 quarters · filed 2026-02-19 | $6.04M derived: sum of 3 quarters · filed 2026-08-06 | $7.91M 10-K · filed 2026-02-19 |
| 2025-09-30 | $2.06M 10-Q · filed 2025-11-06 | $3.97M derived: sum of 2 quarters · filed 2026-08-06 | $5.83M 10-Q · filed 2025-11-06 | $7.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.91M 10-Q · filed 2026-08-06 | $3.77M 10-Q · filed 2026-08-06 | $5.63M derived: sum of 3 quarters · filed 2026-08-06 | $7.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.86M 10-Q · filed 2026-05-07 | $3.72M derived: sum of 2 quarters · filed 2026-05-07 | $5.59M derived: sum of 3 quarters · filed 2026-05-07 | $7.38M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.73M derived: sum of 2 quarters · filed 2026-02-19 | $5.52M derived: sum of 3 quarters · filed 2026-02-19 | $7.42M 10-K · filed 2026-02-19 |
| 2024-09-30 | $1.86M 10-Q · filed 2025-11-06 | $3.66M derived: sum of 2 quarters · filed 2025-11-06 | $5.55M 10-Q · filed 2025-11-06 | $7.36M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.79M 10-Q · filed 2025-08-06 | $3.69M 10-Q · filed 2025-08-06 | $5.49M derived: sum of 3 quarters · filed 2026-02-19 | $10.33M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $1.90M 10-Q · filed 2025-04-30 | $3.70M derived: sum of 2 quarters · filed 2026-02-19 | $8.54M derived: sum of 3 quarters · filed 2026-02-19 | $10.14M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $6.64M derived: sum of 2 quarters · filed 2026-02-19 | $8.25M derived: sum of 3 quarters · filed 2026-02-19 | $9.88M 10-K · filed 2026-02-19 |
| 2023-09-30 | $4.84M 10-Q · filed 2024-11-06 | $6.45M derived: sum of 2 quarters · filed 2024-11-06 | $8.08M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $1.60M 10-Q · filed 2024-08-01 | $3.24M 10-Q · filed 2024-08-01 | ||
| 2022-12-31 | $6.21M 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |